,,ii  #aai? ,,congress  #b;d ,session   
,s4 #ebcg  ,,9 ,,! ,,s5ate ,,( ,,!      
,,unit$ ,,/ates  ,augu/ #d1 #bjbf,ms4   
,hassan 7= h]self & ,mr4 ,m>%all7       
introduc$ ! foll[+ bill2 :i* 0 read     
twice & ref]r$ to ! ,committee on       
,heal?1 ,education1 ,labor1 & ,p5sions  
,a ,,bill  ,to require ! ,director ( !  
,national ,in/itute ( ,all]gy &         
,infecti\s ,diseases to aw>d a          
competitive grant = ! ,antibiotic       
,resi/ance ,lead]%ip ,gr\p = ! purpose (
 facilitat+ a cl9ical rese>* network on 
antibiotic resi/ance1 & = o!r purposes4 
#a4 ,%ort title ,?is ,act may be cit$ z 
! ,/op ,sup]bugs ,act4  #b4 ,fund+ =    
antibiotic resi/ance cl9ical rese>*  7a7
 ,9 g5]al ,! ,director ( ! ,national    
,in/itute ( ,all]gy & ,infecti\s        
,diseases %all aw>d a competitive grant 
= ! ,antibiotic ,resi/ance ,lead]%ip    
,gr\p = ! purpose ( facilitat+ a cl9ical
 rese>* network on antibiotic resi/ance1
 :i* %all include focuses on-- 7#a7     
support+ rapid recruitm5t ( cl9ical     

trial p>ticipants2  7#b7 conduct+       
cl9ical trial recruitm5t outrea* 9      
community sett+s2  7#c7 support+ ! pair+
 ( diagno/ic & ph>maceutical innovations
 dur+ cl9ical trials2 &  7#d7 develop+  
pati5t-report$ outcomes 9 cl9ical       
/udies4  7b7 ,au?orization (            
appropriations ,!re is au?oriz$ to be   
appropriat$ to ! ,director ( ! ,national
 ,in/itute ( ,all]gy & ,infecti\s       
,diseases su* sums z may be necess>y to 
c>ry out subsection 7a74